08:00 , Feb 11, 2013 |  BC Week In Review  |  Company News

Orphan Technologies, St. George's University deal

The university granted Orphan Technologies exclusive, worldwide rights to preclinical enzyme replacement therapies (ERTs) OT-15 and OT-81 . OT-15, or Erythrocyte Encapsulated Thymidine Phosphorylase (EE-TP) , is in development for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). The...